Litchfield Hills Research Predicts NextPlat Q2 Earnings

NextPlat Corp. (NASDAQ:NXPL) – Litchfield Hills Research increased their Q2 2027 EPS estimates for shares of NextPlat in a note issued to investors on Thursday, July 16th. Litchfield Hills Research analyst T. O’neill now expects that the company will earn $0.15 per share for the quarter, up from their prior estimate of $0.14. Litchfield Hills Research currently has a “Buy” rating and a $11.00 target price on the stock. The consensus estimate for NextPlat’s current full-year earnings is ($0.55) per share. Litchfield Hills Research also issued estimates for NextPlat’s Q4 2027 earnings at $0.18 EPS and FY2027 earnings at $0.58 EPS.

NextPlat (NASDAQ:NXPL) last issued its earnings results on Thursday, May 14th. The company reported ($0.42) earnings per share (EPS) for the quarter. NextPlat had a negative net margin of 23.14% and a negative return on equity of 58.05%. The firm had revenue of $9.86 million during the quarter.

Other analysts have also recently issued reports about the company. Zacks Research raised NextPlat to a “hold” rating in a research report on Thursday, June 25th. Weiss Ratings raised NextPlat from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, May 11th. One research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, NextPlat currently has an average rating of “Hold” and an average target price of $11.00.

NextPlat Price Performance

Shares of NASDAQ NXPL opened at $5.81 on Friday. The business’s 50 day moving average price is $6.51 and its two-hundred day moving average price is $5.98. The company has a market cap of $15.75 million, a PE ratio of -1.34 and a beta of 1.87. The company has a quick ratio of 2.12, a current ratio of 2.56 and a debt-to-equity ratio of 0.05. NextPlat has a twelve month low of $3.38 and a twelve month high of $11.10.

Hedge Funds Weigh In On NextPlat

A hedge fund recently bought a new stake in NextPlat stock. Citadel Advisors LLC bought a new position in shares of NextPlat Corp. (NASDAQ:NXPL) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned 0.19% of NextPlat at the end of the most recent quarter. Hedge funds and other institutional investors own 1.30% of the company’s stock.

About NextPlat

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.